Therapeutic opportunities through modulation of the endocannabinoid system.
Makriyannis
Alexandros
A
University of California, Department of Pharmacology, Irvine, CA 92697-4260, USA.
Mechoulam
Raphael
R
Piomelli
Daniele
D
D000818:Animals; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism* / Q000502:physiology; D002186:Cannabinoids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D055808:Drug Discovery; D063388:Endocannabinoids; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D009829:Oleic Acids / Q000494:pharmacology; D019966:Substance-Related Disorders / Q000188:drug therapy
D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D063388:Endocannabinoids; D009829:Oleic Acids; C440229:Oleylethanolamide